Medicare Enrolled
Dr. Khadijah Shamseddine, M.D.
Neurology · Fort Myers, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shamseddine from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shamseddine?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shamseddine
Dr. Khadijah Shamseddine is a neurology specialist in Fort Myers, FL, with 15 years of NPI registration. Based on federal Medicare data, Dr. Shamseddine performed 1,060 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Shamseddine received a total of $19,046 from 64 pharmaceutical and/or device companies across 659 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shamseddine is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years of NPI registration
▲ Top 30% volume in FL
$19,046 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 118066 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗1,060
Medicare services
Top 30% in FL for neurology
Not available
Unique patients (not deduplicated)
$100
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
752 | $92 | $196 |
| Telehealth consultation, emergency department or initial inpatient, 70+ minutes A telehealth consultation for a patient in the emergency department or as an initial inpatient visit. The service involves communicating with the patient for 70 minutes or more. |
69 | $149 | $514 |
| Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth | 41 | $107 | $348 |
| New patient office visit, complex (60-74 min) | 32 | $141 | $368 |
| Brain stimulator programming, additional 15 minutes Electronic analysis and programming of an implanted brain neurostimulator generator by a qualified health professional. This code applies to each additional 15-minute increment beyond the initial service. |
28 | $35 | $98 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
25 | $117 | $298 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
25 | $145 | $270 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
21 | $345 | $729 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
21 | $52 | $136 |
| Electronic analysis of implanted neurostimulator Electronic evaluation of an implanted brain, spinal cord, or peripheral nerve stimulator device. |
19 | $14 | $100 |
| Brain stimulator programming, first 15 minutes Electronic analysis of an implanted brain, spinal cord, or peripheral neurostimulator generator. This service includes programming the brain stimulator by a qualified health professional for the first 15 minutes. |
15 | $39 | $110 |
| Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth | 12 | $77 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$19,046
Total received (2018-2024)
Avg $2,721/year across 7 years
Top 17% in FL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
64
Companies
659
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,544
2023
$3,327
2022
$2,287
2021
$3,415
2020
$760
2019
$5,090
2018
$1,624
Payments by company (2024)
ABBVIE INC.
$466
UCB, Inc.
$276
Supernus Pharmaceuticals, Inc.
$264
Neurocrine Biosciences, Inc.
$187
Novartis Pharmaceuticals Corporation
$175
Amneal Pharmaceuticals LLC
$150
MDD US Operations, LLC
$130
Teva Pharmaceuticals USA, Inc.
$108
ARGENX US, INC.
$103
PFIZER INC.
$74
Boston Scientific Corporation
$69
Lilly USA, LLC
$64
Eisai Inc.
$61
Biogen, Inc.
$51
ACADIA Pharmaceuticals Inc
$45
Genentech USA, Inc.
$42
Otsuka America Pharmaceutical, Inc.
$39
Merz Pharmaceuticals, LLC
$31
Mallinckrodt Hospital Products Inc.
$29
EMD Serono, Inc.
$27
Lundbeck LLC
$26
LivaNova USA, Inc.
$24
Vanda Pharmaceuticals Inc.
$24
Neurelis, Inc.
$23
Alnylam Pharmaceuticals Inc.
$20
Kyowa Kirin, Inc.
$19
Sumitomo Pharma America, Inc.
$17
Top 3 companies account for 39.6% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie, Inc.
$3,502
AbbVie Inc.
$2,638
Neurocrine Biosciences, Inc.
$1,156
UCB, Inc.
$993
ACADIA Pharmaceuticals Inc
$829
ABBVIE INC.
$715
Biogen, Inc.
$583
Teva Pharmaceuticals USA, Inc.
$573
Novartis Pharmaceuticals Corporation
$500
Lilly USA, LLC
$490
Amgen Inc.
$487
Abbott Laboratories
$481
Amneal Pharmaceuticals LLC
$459
Acorda Therapeutics, Inc
$380
Boston Scientific Corporation
$340
MDD US Operations, LLC
$339
Supernus Pharmaceuticals, Inc.
$309
Alnylam Pharmaceuticals Inc.
$248
Avanir Pharmaceuticals, Inc.
$242
US WorldMeds, LLC
$237
ARGENX US, INC.
$236
Genentech USA, Inc.
$216
Kyowa Kirin, Inc.
$212
Otsuka America Pharmaceutical, Inc.
$205
Sunovion Pharmaceuticals Inc.
$197
Avion Pharmaceuticals
$156
EMD Serono, Inc.
$153
Biohaven Pharmaceutical Holding Company Ltd.
$146
Adamas Pharmaceuticals, Inc.
$144
Lundbeck LLC
$140
Sumitomo Pharma America, Inc.
$135
PFIZER INC.
$121
GE Healthcare
$112
Alexion Pharmaceuticals, Inc.
$109
Neurelis, Inc.
$93
Eisai Inc.
$80
E.R. Squibb & Sons, L.L.C.
$73
GE HealthCare
$72
Corium, LLC
$71
GENZYME CORPORATION
$67
Impax Laboratories, Inc.
$66
Allergan Inc.
$61
Bayer HealthCare Pharmaceuticals Inc.
$53
UPSHER-SMITH LABORATORIES LLC
$51
Allergan, Inc.
$51
Biohaven Pharmaceuticals, Inc.
$45
Janssen Pharmaceuticals, Inc
$43
Grifols USA, LLC
$41
GE HEALTHCARE
$41
Celgene Corporation
$34
Mitsubishi Tanabe Pharma America, Inc.
$34
SK Life Science, Inc.
$33
Merz Pharmaceuticals, LLC
$31
Mallinckrodt Hospital Products Inc.
$29
LivaNova USA, Inc.
$24
Vanda Pharmaceuticals Inc.
$24
EISAI INC.
$21
Horizon Therapeutics plc
$21
IMPEL PHARMACEUTICALS INC.
$21
JAZZ PHARMACEUTICALS INC.
$19
Mallinckrodt LLC
$18
Medtronic USA, Inc.
$16
Promius Pharma LLC
$16
MITSUBISHI TANABE PHARMA AMERICA, INC.
$15
Top 3 companies account for 38.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adempas · Adlarity · Aduhelm · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · COPAXONE · CREXONT · DUOPA · Dhivy · Duopa · EMGALITY · Enspryng · GILENYA · GIVLAARI · GOCOVRI · Gamunex-C · General - DBS · Gocovri · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KYNMOBI · LEMTRADA · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · ONZETRA Xsail · Ocrevus · Ongentys · PONVORY · Ponvory · QULIPTA · Qelbree · RADICAVA · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPINRAZA · Skyclarys · TECFIDERA · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XYWAV · Xadago · Xeomin · ZAVZPRET · ZEMBRACE SYMTOUCH · ZEPOSIA · Zembrace · Zilbrysq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
182
County median income
$73,099
Nearest hospital to ZIP centroid (approximate)
PARK ROYAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shamseddine is a clinical cardiology specialist, with above-average Medicare volume (top 30% in FL), with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shamseddine experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Shamseddine performed 752 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Shamseddine receive payments from pharmaceutical companies?
Yes. Dr. Shamseddine received a total of $19,046 from 64 companies across 659 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shamseddine's costs compare to other neurologists in Fort Myers?
Dr. Shamseddine's average Medicare payment per service is $100. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shamseddine) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Fort Myers
Browse neurologists in Fort Myers ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in FL
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in FL
Which FL neurologists receive the most from drug and device companies.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
Neurocrine Biosciences, Inc. Payments to Doctors
See all physicians who received payments from Neurocrine Biosciences, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology